White label ELPA - ClinicalTrials.eu

Study on the Effectiveness and Safety of Clascoterone Solution for Treating Male Pattern Hair Loss

Not recruiting

3 1 1
Investigated Diseases:
- Androgenetic alopecia
Investigated Drugs:
- Clascoterone
Study of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

Not recruiting

3 1 1
Investigated Diseases:
- Clear cell renal cell carcinoma
Investigated Drugs:
- Belzutifan
- Pembrolizumab
+8
Study on the Effects and Safety of Povorcitinib for Adults with Chronic Spontaneous Urticaria

Not recruiting

2 1
Investigated Drugs:
- Povorcitinib
Study Comparing Integrase Inhibitor (Bictegravir) and Boosted Protease Inhibitor (Darunavir) Treatments for Patients with Advanced HIV Infection

Not recruiting

3 1 1 1
Investigated Diseases:
- HIV infection
Investigated Drugs:
Study on [68Ga]Ga-FAPI-46 and Iodixanol for Better Imaging in Patients with Pancreatic and Gastroesophageal Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Gastrooesophageal cancer
- Pancreatic carcinoma
Investigated Drugs:
- Iodixanol
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

Not recruiting

3 1
Investigated Drugs:
- Upadacitinib
+10
Study of ART0380 for Patients with Advanced or Metastatic Solid Tumors

Not recruiting

2 1 1
Investigated Diseases:
- Neoplasm malignant
Study on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis

Not recruiting

2 1 1
Investigated Diseases:
- Deep vein thrombosis
- Thrombolysis
Investigated Drugs:
- Bay 3018250
+5
Study of Avutometinib, Sotorasib, and Defactinib for Patients with KRAS G12C Mutant Non-Small Cell Lung Cancer

Not recruiting

1 1 1 1
Investigated Drugs:
Study on 68Ga-FAPI-46 and Fludeoxyglucose (18F) for Diagnosing Stomach and Gastroesophageal Junction Cancer in Patients Undergoing Chemotherapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Gastric cancer
- Gastrooesophageal cancer
Investigated Drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
- Fludeoxyglucose (18F)

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies